Gram-negative Bacteremia clinical trials at UCSF

1 research study open to eligible people

Gram-negative bacteremia is an infection in the bloodstream caused by certain bacteria. UCSF is studying if oral antibiotics can be used to treat these infections. These trials involve random assignments and are conducted in multiple locations.

Showing trials for

  • Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

    open to eligible people ages 18 years and up

    The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.

    San Francisco, California and other locations

Our lead scientists for Gram-negative Bacteremia research studies include .

Last updated: